Precision Medicine for Patients With Identified Actionable Mutations

Clinical trial NCT04111107 · TERMINATED

Trial details

NCT number: NCT04111107
Sponsor: Wake Forest University Health Sciences
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumor Lymphoma Multiple Myeloma Malignant Neoplasm Mutation Abnormality

Start date: 2020-04-22
Primary completion: 2022-12-09
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.